MacSweeney, a Consultant Interventional Neuro-Radiologist, co-founded Re:Cognition Health in 2011 to provide a specialist service for accurate diagnosis and access to the latest treatments for progressive neurodegenerative & neurodevelopmental conditions and traumatic brain injury.  Re:Cognition Health has 10 Centres in the UK & USA, where  individuals can enter global clinical trials for new diagnostic biomarkers and emerging brain and mind medications. 
 
The focus Dr MacSweeney and her team of Brain and Mind Experts are deploying on Alzheimer’s Disease (a global pandemic) now includes providing treatment with the recently approved monoclonal antibodies against amyloid in UK & USA.